AllSquare Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

AllSquare Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$67.4K	Sell	467 -100	-18%	-$13.7K	0.04%	206
2025 Q2	$71.7K	Hold	567	–	–	0.04%	186
2025 Q1	$72.5K	Hold	567	–	–	0.04%	177
2024 Q4	$75K	Hold	567	–	–	0.04%	172
2024 Q3	$82.6K	Hold	567	–	–	0.05%	167
2024 Q2	$77.8K	Sell	567 -30	-5%	-$4K	0.05%	168
2024 Q1	$81.9K	Hold	597	–	–	0.05%	172
2023 Q4	$81.1K	Hold	597	–	–	0.05%	167
2023 Q3	$73K	Hold	597	–	–	0.05%	167
2023 Q2	$75.3K	Hold	597	–	–	0.05%	169
2023 Q1	$77.1K	Hold	597	–	–	0.05%	171
2022 Q4	$78.4K	Hold	597	–	–	0.05%	156
2022 Q3	$70K	Hold	597	–	–	0.05%	157
2022 Q2	$70K	Hold	597	–	–	0.05%	164
2022 Q1	$78K	Sell	597 -25	-4%	-$3.26K	0.05%	172
2021 Q4	$95K	Hold	622	–	–	0.06%	157
2021 Q3	$101K	Sell	622 -100	-14%	-$16.8K	0.06%	143
2021 Q2	$118K	Buy	722 +50	+7%	+$7.7K	0.07%	140
2021 Q1	$101K	Hold	672	–	–	0.06%	149
2020 Q4	$102K	Sell	672 -300	-31%	-$42.9K	0.07%	139
2020 Q3	$132K	Hold	972	–	–	0.1%	111
2020 Q2	$133K	Buy	972 +39	+4%	+$4.97K	0.1%	103
2020 Q1	$101K	Hold	933	–	–	0.09%	118
2019 Q4	$112K	Hold	933	–	–	0.08%	120
2019 Q3	$93K	Hold	933	–	–	0.07%	132
2019 Q2	$102K	Buy	933 +529	+131%	+$56.3K	0.08%	122
2019 Q1	$45K	Buy	404 +70	+21%	+$7.68K	0.03%	200
2018 Q4	$32K	Sell	334 -200	-37%	-$21.2K	0.03%	213
2018 Q3	$65K	Hold	534	–	–	0.05%	151
2018 Q2	$59K	Sell	534 -200	-27%	-$21.4K	0.04%	162
2018 Q1	$78K	Sell	734 -100	-12%	-$11.1K	0.06%	123
2017 Q4	$89K	Hold	834	–	–	0.07%	110
2017 Q3	$93K	Buy	+834	New	+$89.1K	0.08%	103
2017 Q2	–	Sell	-834	Closed	-$82K	–	265
2017 Q1	$82K	Hold	834	–	–	0.07%	103
2016 Q4	$74K	Hold	834	–	–	0.07%	108
2016 Q3	$80K	Hold	834	–	–	0.08%	92
2016 Q2	$72K	Hold	834	–	–	0.07%	93
2016 Q1	$73K	Sell	834 -1,350	-62%	-$121K	0.07%	93
2015 Q4	$246K	Sell	2,184 -195	-8%	-$21.2K	0.25%	47
2015 Q3	$241K	Sell	2,379 -45	-2%	-$5.4K	0.25%	43
2015 Q2	$298K	Buy	2,424 +84	+4%	+$10.1K	0.28%	37
2015 Q1	$268K	Buy	2,340 +195	+9%	+$21.5K	0.26%	42
2014 Q4	$217K	Buy	+2,145	New	+$208K	0.21%	50

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AllSquare Wealth Management's IBB Position: Q3 2025 in Review

AllSquare Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 18% in Q3 2025, selling an estimated $13.7K and leaving 467 shares worth $67.4K. The position accounts for 0.04% of the portfolio, ranked #206.

AllSquare Wealth Management first reported a position in IBB in Q4 2014 and has held it in 43 quarters since. The position peaked at $298K in Q2 2015. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

AllSquare Wealth Management held 467 shares of iShares Biotechnology ETF worth $67.4K as of Q3 2025.
AllSquare Wealth Management sold 100 iShares Biotechnology ETF shares in Q3 2025, an estimated $13.7K.
iShares Biotechnology ETF made up 0.04% of AllSquare Wealth Management's portfolio in Q3 2025, its #206 holding.
AllSquare Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2014 and has held it in 43 quarters since.
AllSquare Wealth Management's iShares Biotechnology ETF position peaked at $298K in Q2 2015.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.